Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Clinical characteristics of the study population

From: Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients

Characteristics Prostate cancer, n = 50 Benign prostatic hyperplasia, n = 22
Age (years)
 Mean ± SD 66 ± 7 61 ± 8
 Median (range) 65 (54–85) 60 (44–75)
 Missing 1 4
Serum PSA (ng/ml)
 0–4.0 3 (6%) 9 (41%)
 4.1–20.0 31 (62%) 13 (59%)
 > 20.0 15 (30%) 0 (0%)
 Missing 1 (2%) 0 (0%)
Gleason score
 4–6 26 (52%)
 8–9 24 (48%)
Metastasis status
 M0 39 (78%)
 M1 3 (6%)
 Missing 8 (16%)
Cancer grade
 G1 0 (0%)
 G2 11 (22%)
 G3 12 (24%)
 Missing 27 (54%)
Prostatitis
 – 40 (80%) 11 (50%)
 + 8 (16%) 11 (50%)
 Missing 2 (4%) 0 (0%)